Serum selenium concentrations in patients with autoimmune thyroiditis and non-toxic nodular goiter
(1993) In Thyroidology 5(1). p.4-21- Abstract
Selenium (Se) deficiency is said to contribute to the atrophy of the thyroid gland in certain endemic goiter areas in Africa. To test the hypothesis that, a low Se intake could protect against goiter development in autoimmune thyroiditis, we analysed the Se concentration in 20 patients with the atrophic variant of lymphocytic thyroiditis, 23 patients with Hashimoto's thyroiditis and 23 patients with non-toxic nodular (colloid) goiter. Twenty healthy females served as controls. We did not find any significant difference in serum selenium (S-Se) levels between the patients with the various thyroid disorders or between patients and controls. There was no difference in the S-Se concentration and the triiodothyronine (T3), thyroxine (T4),... (More)
Selenium (Se) deficiency is said to contribute to the atrophy of the thyroid gland in certain endemic goiter areas in Africa. To test the hypothesis that, a low Se intake could protect against goiter development in autoimmune thyroiditis, we analysed the Se concentration in 20 patients with the atrophic variant of lymphocytic thyroiditis, 23 patients with Hashimoto's thyroiditis and 23 patients with non-toxic nodular (colloid) goiter. Twenty healthy females served as controls. We did not find any significant difference in serum selenium (S-Se) levels between the patients with the various thyroid disorders or between patients and controls. There was no difference in the S-Se concentration and the triiodothyronine (T3), thyroxine (T4), thyrotropin (TSH) or thyroglobulin concentrations in serum. Thus, the Se status had no impact on the development of goiter.
(Less)
- author
- Ericsson, U B ; Erfurth, E M LU and Schütz, A LU
- publishing date
- 1993
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- Adult, Female, Goiter, Nodular/blood, Humans, Male, Middle Aged, Selenium/blood, Thyroiditis, Autoimmune/blood, Thyrotropin/blood, Thyroxine/blood, Triiodothyronine/blood
- in
- Thyroidology
- volume
- 5
- issue
- 1
- pages
- 4 - 21
- publisher
- Pacini Editore s.r.l.
- external identifiers
-
- scopus:0027573277
- pmid:7508739
- ISSN
- 1121-7596
- language
- English
- LU publication?
- no
- id
- 1589bfc6-2ed7-4828-b008-b7a3d7be51e4
- date added to LUP
- 2023-11-27 09:52:00
- date last changed
- 2024-01-10 11:53:00
@article{1589bfc6-2ed7-4828-b008-b7a3d7be51e4,
abstract = {{<p>Selenium (Se) deficiency is said to contribute to the atrophy of the thyroid gland in certain endemic goiter areas in Africa. To test the hypothesis that, a low Se intake could protect against goiter development in autoimmune thyroiditis, we analysed the Se concentration in 20 patients with the atrophic variant of lymphocytic thyroiditis, 23 patients with Hashimoto's thyroiditis and 23 patients with non-toxic nodular (colloid) goiter. Twenty healthy females served as controls. We did not find any significant difference in serum selenium (S-Se) levels between the patients with the various thyroid disorders or between patients and controls. There was no difference in the S-Se concentration and the triiodothyronine (T3), thyroxine (T4), thyrotropin (TSH) or thyroglobulin concentrations in serum. Thus, the Se status had no impact on the development of goiter.</p>}},
author = {{Ericsson, U B and Erfurth, E M and Schütz, A}},
issn = {{1121-7596}},
keywords = {{Adult; Female; Goiter, Nodular/blood; Humans; Male; Middle Aged; Selenium/blood; Thyroiditis, Autoimmune/blood; Thyrotropin/blood; Thyroxine/blood; Triiodothyronine/blood}},
language = {{eng}},
number = {{1}},
pages = {{4--21}},
publisher = {{Pacini Editore s.r.l.}},
series = {{Thyroidology}},
title = {{Serum selenium concentrations in patients with autoimmune thyroiditis and non-toxic nodular goiter}},
volume = {{5}},
year = {{1993}},
}